Lipocine Inc.

LPCN·NASDAQ·$2.26Share Price as of 11/2·$13MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/04/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/10/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report10/20/26 8-KCurrent report10/07/26 8-KCurrent report09/16/26 8-KCurrent report09/14/26 8-KCurrent report09/11/26

Prospectuses and Registrations

S-8Registration of securities for employees06/09/26 424B5Prospectus supplement02/26/26 424B5Prospectus supplement04/26/24 S-3/AShelf registration (amended)04/23/24 S-3Shelf registration11/22/23

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 DEF 14ADefinitive proxy04/22/25 PRE 14APreliminary proxy04/10/25 DEFA14AAdditional proxy materials06/03/24

Ownership

Form 4Insider transaction10/01/26 Form 4Insider transaction09/30/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 3Initial insider ownership08/07/26 Form 4Insider transaction08/07/26

Other

EFFECTRequest for effectiveness04/25/24 CORRESPCorrespondence with the SEC04/24/24 UPLOADLetter from the SEC11/29/23 ARSAnnual report to shareholders03/20/23 8-A12G8-A12G03/10/23